• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平对心绞痛患者运动耐量的影响。

Effect of nifedipine on exercise tolerance in patients with angina pectoris.

作者信息

Atterhög J H, Ekelund L G, Melin A L

出版信息

Eur J Clin Pharmacol. 1975 Feb 28;8(2):125-30. doi: 10.1007/BF00561561.

DOI:10.1007/BF00561561
PMID:786677
Abstract

To test if nifedipine, 10 mg sublingually, could increase exercise tolerance, ten patients with angina pectoris each performed two types of bicycle exercise test, one with a stepwise increase in load and the other with a continuously increasing load. The drug was given in a double-blind cross-over trial. Nifedipine raised the heart rate and diminished the systemic blood pressure at rest, on standing and during exercise at comparable loads. Work time was prolonged and higher work loads were achieved. The total work performed rose by 50 per cent in one of the tests and by 23 per cent in the other, about 50 minutes after taking the drug. The mechanism of the greater work capacity in angina pectoris after nifedipine was assumed to be diminished heart work due to a fall in systemic vascular resistance.

摘要

为了测试舌下含服10毫克硝苯地平是否能提高运动耐量,10名心绞痛患者每人进行了两种类型的自行车运动试验,一种是负荷逐步增加,另一种是负荷持续增加。该药物在双盲交叉试验中给药。硝苯地平在静息、站立及同等负荷运动时均能提高心率并降低体循环血压。运动时间延长,且能达到更高的工作负荷。服药后约50分钟,在其中一项试验中总工作量增加了50%,在另一项试验中增加了23%。硝苯地平治疗后心绞痛患者工作能力增强的机制被认为是由于体循环血管阻力下降导致心脏做功减少。

相似文献

1
Effect of nifedipine on exercise tolerance in patients with angina pectoris.硝苯地平对心绞痛患者运动耐量的影响。
Eur J Clin Pharmacol. 1975 Feb 28;8(2):125-30. doi: 10.1007/BF00561561.
2
Effect of a calcium inhibitor, nifedipine, on exercise tolerance in patients with angina pectoris: a double-blind study.
Chest. 1981 Mar;79(3):302-5. doi: 10.1378/chest.79.3.302.
3
Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study.硝苯地平联合或不联合β受体阻滞剂的抗心绞痛疗效,通过运动试验进行研究。一项双盲、随机亚急性研究。
Clin Cardiol. 1979 Jun;2(3):203-11. doi: 10.1002/clc.4960020306.
4
Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris.
Am J Cardiol. 1994 Apr 1;73(9):658-60. doi: 10.1016/0002-9149(94)90929-6.
5
Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris.
Eur Heart J. 1983 Dec;4(12):873-81. doi: 10.1093/oxfordjournals.eurheartj.a061415.
6
Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.对于正在服用缓释硝苯地平的心绞痛患者,添加直接窦房结抑制剂扎替雷定并不能带来更大的运动耐量益处:一项多中心、随机、双盲、安慰剂对照、平行组研究的结果。扎替雷定研究组
J Am Coll Cardiol. 1995 Aug;26(2):305-12. doi: 10.1016/0735-1097(95)80000-7.
7
Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina.
Am J Cardiol. 1982 Oct;50(4):689-95. doi: 10.1016/0002-9149(82)91220-6.
8
Effect of nifedipine on exercise tolerance in angina pectoris.硝苯地平对心绞痛患者运动耐量的影响。
Br Heart J. 1980 Sep;44(3):335-41. doi: 10.1136/hrt.44.3.335.
9
Effects of Adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
Cathet Cardiovasc Diagn. 1976;2(4):361-7. doi: 10.1002/ccd.1810020410.
10
Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.地尔硫䓬与硝苯地平治疗心绞痛和全身性高血压的比较。
Am J Cardiol. 1985 Dec 6;56(16):41H-46H. doi: 10.1016/0002-9149(85)90542-9.

引用本文的文献

1
The combination of nifedipine and propranolol in the management of patients with angina pectoris.硝苯地平与普萘洛尔联合用于治疗心绞痛患者。
Br J Clin Pharmacol. 1981 Aug;12(2):229-33. doi: 10.1111/j.1365-2125.1981.tb01205.x.
2
Haemodynamic dose-response effects of intravenous nisoldipine in coronary artery disease.静脉注射尼索地平对冠状动脉疾病的血流动力学剂量反应效应。
Br J Clin Pharmacol. 1985 Dec;20(6):675-80. doi: 10.1111/j.1365-2125.1985.tb05127.x.
3
A haemodynamic and radionuclide assessment of diltiazem in coronary heart disease.

本文引用的文献

1
CIRCULATORY STUDIES ON HEALTHY OLD MEN. WITH SPECIAL REFERENCE TO THE LIMITATION OF THE MAXIMAL PHYSICAL WORKING CAPACITY.健康老年男性的循环系统研究。特别提及最大体力工作能力的限制。
Acta Med Scand Suppl. 1964;414:SUPPL 414:1-44.
2
Perceived exertion as an indicator of somatic stress.自觉用力程度作为躯体应激的一个指标。
Scand J Rehabil Med. 1970;2(2):92-8.
3
[Effect of BAY a 1040 on renal function in hypertension].
Arzneimittelforschung. 1972 Feb;22(2):377-80.
地尔硫䓬在冠心病中的血流动力学及放射性核素评估
Br J Clin Pharmacol. 1987 Feb;23(2):165-72. doi: 10.1111/j.1365-2125.1987.tb03025.x.
4
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.硝苯地平在冠状动脉疾病中的药代动力学、血流动力学及放射性核素研究。
Eur J Clin Pharmacol. 1986;29(6):651-7. doi: 10.1007/BF00615954.
5
Changes in haemodynamics and left ventricular function during intravenous nifedipine infusion with and without additional propranolol in patients with coronary artery disease. A randomized, placebo controlled trial.冠状动脉疾病患者在静脉输注硝苯地平(无论是否加用普萘洛尔)过程中的血流动力学和左心室功能变化。一项随机、安慰剂对照试验。
Eur J Clin Pharmacol. 1987;33(4):345-8. doi: 10.1007/BF00637628.
6
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.钙通道拮抗剂。第二部分:三种典型钙通道拮抗剂在缺血性心脏病中的应用及比较特性,包括基于41项试验分析的推荐意见。
Cardiovasc Drugs Ther. 1988 Jan;1(5):461-91. doi: 10.1007/BF02125731.
7
An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.维拉帕米、地尔硫䓬和氨氯地平在冠状动脉疾病中的运动血流动力学比较。
Cardiovasc Drugs Ther. 1990 Apr;4(2):457-63. doi: 10.1007/BF01857754.
8
Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.氨氯地平对冠状动脉疾病的血流动力学及放射性核素影响
Br J Clin Pharmacol. 1990 Apr;29(4):437-45. doi: 10.1111/j.1365-2125.1990.tb03662.x.
9
Effects of nifedipine on cardiac function in patients with coronary artery disease evaluated with ambulatory radionuclide monitoring.硝苯地平对冠状动脉疾病患者心功能影响的动态放射性核素监测评估
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:919-22. doi: 10.1007/BF02018293.
10
Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.新型β受体阻滞剂塞利洛尔与硝苯地平在心绞痛中的血流动力学相互作用
Cardiovasc Drugs Ther. 1991 Aug;5(4):681-7. doi: 10.1007/BF03029741.
4
[The indicative value of central hemodynamic changes following the administration of an o-nitrophenyl-dihydropyridine derivative].[邻硝基苯基二氢吡啶衍生物给药后中心血流动力学变化的指示价值]
Arzneimittelforschung. 1972 Feb;22(2):373-7.
5
[Effect of Nifedipine (BAY a 1040) on work electrocardiogram of angina pectoris patients].硝苯地平(BAY a 1040)对心绞痛患者运动心电图的影响
Arzneimittelforschung. 1972 Feb;22(2):358-62.
6
[The effect of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester on myocardial metabolism, hemodynamics, blood gases and general metabolism of man].4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸甲酯对人体心肌代谢、血液动力学、血气及一般代谢的影响
Arzneimittelforschung. 1972 Feb;22(2):353-8.
7
Cardiohemodynamic effects of BAY a 1040 in the dog.BAY a 1040对犬的心脏血液动力学影响。
Arzneimittelforschung. 1972 Jan;22(1):15-21.
8
The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.采用序贯分析法评估4-(2'-硝基苯基)-2,6-二甲基-3,5-二羧酸甲酯基-1,4-二氢吡啶(BAY a 1040)对心绞痛的临床疗效。
Arzneimittelforschung. 1972 Feb;22(2):365-7.
9
[Changed hemodynamics of the left heart under the influence of Nifedipine (BAY a 1040) as compared to nitroglycerin].硝苯地平(BAY a 1040)与硝酸甘油相比对左心血流动力学的影响
Arzneimittelforschung. 1972 Feb;22(2):362-5.
10
[Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].[血管平滑肌的机电解偶联作为4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯(BAY a 1040,硝苯地平)冠脉扩张的基本原理。1. Ca++离子对平滑肌生物电和机械活动的意义]
Arzneimittelforschung. 1972 Feb;22(2):334-44.